AbbVie, Inc. (ABBV)
227.46
+6.57
(+2.97%)
USD |
NYSE |
Feb 12, 16:00
227.41
-0.05
(-0.02%)
After-Hours: 20:00
AbbVie Free Cash Flow : 19.68B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 9.958B |
| Biogen, Inc. | 1.969B |
| Gilead Sciences, Inc. | 10.02B |
| Johnson & Johnson | 20.46B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |